EMIS Group PLC Directorate Changes (8085X)
02 May 2019 - 4:00PM
UK Regulatory
TIDMEMIS
RNS Number : 8085X
EMIS Group PLC
02 May 2019
2 May 2019
EMIS Group plc ("EMIS Group" or the "Company")
Directorate changes
EMIS Group, the UK leader in connected healthcare software and
services, today announces the retirement of Robin Taylor and the
appointment of Jennifer Byrne to the Board as an independent
Non-executive Director.
Robin will retire at the conclusion of the 2019 Annual General
Meeting (AGM) on 8 May 2019, after nine years of service with EMIS
Group as Senior Non-executive Independent Director and Chair of its
audit committee. Andy McKeon, Non-executive Director, who has been
on the Board since 2013 will step up to the role of Senior
Independent Director, while Kevin Boyd, Non-executive Director,
will become Chair of the audit committee.
Jennifer Byrne will be formally appointed as an independent
Non-executive Director immediately following the 2019 AGM on 8 May
2019, bringing her wealth of experience in the global software
sector to the leadership team. She will join the EMIS Group Board's
audit, remuneration and nomination committees.
Jennifer served Lockheed Martin for over twenty five years in a
series of high ranking roles including Vice President of Space
Systems Engineering and Technology where her staff numbered in
excess of 10,000. She has extensive experience of successful
delivery of large scale mission critical products, projects and
systems in highly complex environments. More recently, Jennifer
relocated to the UK to take on the position of Chief Operating
Officer at G-Research, a quantitative research and technology
company that produces predictive research and builds advanced data
analytics technology.
Mike O'Leary, Chairman of EMIS Group, said: "Robin has completed
nine years of service with EMIS Group and on behalf of his
colleagues, I would like to thank him sincerely for his advice and
continued support throughout. We wish him a long and happy
retirement.
"It gives me great pleasure to welcome Jennifer Byrne to the
Board. Her wealth of commercial experience and background in using
technical insight to deliver challenging and technically complex
engineering programmes, will complement and enhance the significant
expertise we already have on the Board."
Appendix:
Full name: Jennifer Byrne
Age: 55
Current Directorships: None
Directorships held in the past five years: None
There are no further disclosures to be made in connection with
Schedule Two of paragraph (g) of the AIM rules for companies in
connection with this appointment.
- ENDS -
For further information, contact:
EMIS Group plc Tel: 0113 380 3000
Andy Thorburn, CEO
Peter Southby, CFO
www.emisgroupplc.com
@EMISGroup
Numis Securities Limited (Nominated Adviser & Broker) Tel: 020 7260 1000
Oliver Hardy/Simon Willis/James Black
MHP Communications Tel: 020 3128 8572
Reg Hoare/Giles Robinson/Patrick Hanrahan/Florence Mayo
Notes to Editors
EMIS Group is the UK leader in connected healthcare software and
services. Its solutions are widely used across every major UK
healthcare setting from primary, community & acute care, to
high street pharmacies. EMIS Group helps healthcare professionals
in over 10,000 organisations share vital information, facilitating
better, more efficient healthcare and supporting longer and
healthier lives.
EMIS Group serves the following healthcare markets under the
EMIS Health brand:
-- Primary, Community & Acute Care, as the UK leader in
clinical management systems for healthcare providers and
commissioners. EMIS Health products, including the flagship EMIS
Web, hold over 40 million patient records and are used by more than
100,000 professionals in nearly 6,000 healthcare organisations.
-- Community Pharmacy, with the UK's single most used integrated
community pharmacy and retail system.
These markets are also supported by other EMIS Group
businesses:
-- under the Patient brand, the UK's leading independent
provider of patient-centric medical and wellbeing information and
related transactional services.
-- under the Egton brand, providing specialist ICT
infrastructure, hardware and engineering services, and non-clinical
software into health and social care.
-- under the Dovetail Lab brand, a health technology company
developing blockchain software to facilitate the integration of
healthcare data.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BOASSFFMFFUSESI
(END) Dow Jones Newswires
May 02, 2019 02:00 ET (06:00 GMT)
Emis (LSE:EMIS)
Historical Stock Chart
From Apr 2024 to May 2024
Emis (LSE:EMIS)
Historical Stock Chart
From May 2023 to May 2024